Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


SQZ Biotechnologies Co (SQZ) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/26/2023 4 Capasso Richard (See Remarks) has filed a Form 4 on SQZ Biotechnologies Co
Txns: Granted 213,000 options @ $0.73, valued at $155.5k
01/26/2023 4 Warren Marshelle Smith (Chief Medical Officer) has filed a Form 4 on SQZ Biotechnologies Co
Txns: Granted 261,000 options @ $0.73, valued at $190.5k
01/26/2023 4 Knopf Lawrence J (General Counsel) has filed a Form 4 on SQZ Biotechnologies Co
Txns: Granted 227,000 options @ $0.73, valued at $165.7k
01/26/2023 4 First David (Chief People Officer) has filed a Form 4 on SQZ Biotechnologies Co
Txns: Granted 200,000 options @ $0.73, valued at $146k
01/26/2023 4 BERNSTEIN HOWARD PHD MD (Interim Chief Executive Office) has filed a Form 4 on SQZ Biotechnologies Co
Txns: Granted 830,000 options @ $0.73, valued at $605.9k
08/16/2022 4 Capasso Richard (See Remarks) has filed a Form 4 on SQZ Biotechnologies Co
Txns: Sold 1,183 shares @ $3.3262, valued at $3.9k
07/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2022 4 Capasso Richard (See Remarks) has filed a Form 4 on SQZ Biotechnologies Co
Txns: Granted 1,183 shares @ $2.703, valued at $3.2k
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Coulie Bernard (Director) has filed a Form 4 on SQZ Biotechnologies Co
Txns: Granted 20,000 options @ $3.23, valued at $64.6k
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/15/2022 4 First David (Chief People Officer) has filed a Form 4 on SQZ Biotechnologies Co
Txns: Granted 66,000 options @ $6.57, valued at $433.6k
02/15/2022 4 Zajic Micah (Chief Business Officer) has filed a Form 4 on SQZ Biotechnologies Co
Txns: Granted 80,000 options @ $6.57, valued at $525.6k
02/15/2022 4 Capasso Richard (See Remarks) has filed a Form 4 on SQZ Biotechnologies Co
Txns: Granted 42,000 options @ $6.57, valued at $275.9k
02/15/2022 4 Sharei Armon (President and CEO) has filed a Form 4 on SQZ Biotechnologies Co
Txns: Granted 395,000 options @ $6.57, valued at $2.6M
02/15/2022 4 Knopf Lawrence J (General Counsel) has filed a Form 4 on SQZ Biotechnologies Co
Txns: Granted 97,000 options @ $6.57, valued at $637.3k
02/15/2022 4 BERNSTEIN HOWARD PHD MD (Chief Scientific Officer) has filed a Form 4 on SQZ Biotechnologies Co
Txns: Granted 195,000 options @ $6.57, valued at $1.3M
01/13/2022 4 Sharei Armon (President and CEO) has filed a Form 4 on SQZ Biotechnologies Co
Txns: Exercised 13,000 options @ $1.81, valued at $23.5k
01/04/2022 4 Sharei Armon (President and CEO) has filed a Form 4 on SQZ Biotechnologies Co
Txns: Granted 1,686 shares @ $7.5905, valued at $12.8k
01/04/2022 4 Knopf Lawrence J (General Counsel) has filed a Form 4 on SQZ Biotechnologies Co
Txns: Granted 454 shares @ $7.5905, valued at $3.4k
12/23/2021 4 SCHULMAN AMY W (10% Owner) has filed a Form 4 on SQZ Biotechnologies Co
Txns: Exercised 10,091 options @ $2.02, valued at $20.4k
Exercised 7,458 options @ $4.59, valued at $34.2k
Exercised 6,581 options @ $4.59, valued at $30.2k
12/22/2021 4 Sharei Armon (President and CEO) has filed a Form 4 on SQZ Biotechnologies Co
Txns: Exercised 11,049 options @ $1.81, valued at $20k
12/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy